MedTrace Logo

Exercise Study for Breast Cancer Survivors

NCT04208074 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-02-28

No results posted yet for this study

Summary

This study evaluates the link between muscle health and immune health in breast cancer survivors. Regular exercise is known to improve overall survival in cancer patients but the mechanism is not known. In this study the investigators will evaluate if improving muscle mass and strength via exercise improves the immune system's ability to fight cancer.

This is a one armed study where in 30 breast cancer survivors will be recruited to a 4 month exercise intervention. Increase in muscle mass and strength will be correlated with immune cell frequency and function.

Conditions

Interventions

OTHER

Exercise Intervention

Participants will exercise under the supervision of expert personal trainers and follow an optimized exercise program tailored to the strength and fitness level of each participant. Participants will exercise for 16 weeks; 2 days a week at the gym for an hour and 2 days of the week at home for 45 minutes.

Sponsors & Collaborators

  • California Breast Cancer Research Program

    collaborator OTHER

  • Arizona State University

    collaborator OTHER

  • Tri-City Wellness & Fitness Center

    collaborator UNKNOWN

  • We Support U

    collaborator UNKNOWN

  • San Diego Biomedical Research Institute

    lead OTHER

Principal Investigators

  • Joanna D Davies, PhD · San Diego Biomedical Research Institute

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-25
Primary Completion
2020-07-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208074 on ClinicalTrials.gov